Cagent Vascular's Series B Round

Cagent Vascular raised a round of funding on July 12, 2018.

Cagent Vascular is a developer of technology for vessel dilatation in cardiovascular disease interventions. The Serranator is the company's first product and is an angioplasty balloon which incorpora…

Articles about Cagent Vascular's Series B Round: